 A BLINDED STUDY CONDUCTED AT MULTIPLE CENTERS EVALUATING VARIOUS DOSES OF AN INVESTIGATIONAL AGENT BO-653 AGA PLACEBO, FOR SAFETY AND EFFECTIVENESS IN PREVENTING POST-ANGIOPLASTY BLOOD VESSEL RE-CLOSURE RESTENOSIS IN STENTED VESSELS.: 